EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Breast Cancer

ISSN 1340-6868 · Springer Science and Business Media LLC

Latest articles

  1. Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study

    Takayuki Iwamoto, Yukari Uemura, Takashi Ishikawa, Azusa Jo, Hirohito Seki, Masahiro Kitada, Tsuyoshi Saito, Kimito Yamada, Shintaro Takao, Daisuke Takabatake, Toru Yokota, Yasuo Hozumi, Yuichiro Kikawa, Akimitsu Yamada, Uhi Toh, Hideki Nishimura, Hiroshi Kaise, Kazuhiko Yamagami, Reiki Nishimura, Kazutaka Narui, Hirofumi Mukai, Naruto Taira

    Published: 2026-11-06DOI: 10.1007/s12282-026-01936-2

  2. Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression

    Masayuki Nagahashi, Hiraku Kumamaru, Naoko Kinukawa, Takayuki Iwamoto, Masahiro Kawashima, Takayuki Kinoshita, Takaaki Konishi, Yasuaki Sagara, Shinsuke Sasada, Shigehira Saji, Naoko Sanuki, Kenta Tanakura, Naoki Niikura, Minoru Miyashita, Masayuki Yoshida, Takanori Ishida, Naruto Taira

    Published: 2025-03DOI: 10.1007/s12282-025-01671-0

Volumes

2026 · 1312025 · 1492024 · 1242023 · 1092022 · 1152021 · 1472020 · 1402019 · 1042018 · 1002017 · 1082016 · 1242015 · 922014 · 1122013 · 592012 · 602011 · 552010 · 582009 · 572008 · 582007 · 742006 · 692005 · 682004 · 692003 · 632002 · 642001 · 592000 · 721999 · 691998 · 661997 · 551996 · 351995 · 211994 · 24

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.